ADXN Addex Therapeutics Ltd
Healthcare$6.75-1.17%ClosedMarket Cap: $4.9M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.41
P/S
46.87
EV/EBITDA
-0.96
DCF Value
$1.47
FCF Yield
-30.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
-4.8%
Operating Margin
-1839.8%
Net Margin
-4398.5%
ROE
-102.6%
ROA
-105.8%
ROIC
-54.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $248.00 | 100.0% | $-779.3K | $-1.8M | $— | — |
| FY null | $30.0K | 100.0% | $-2.8M | $-6.4M | $— | — |
| Q3 null | $29.7K | 100.0% | $-696.2K | $-1.6M | $— | — |
| Q2 null | $36.4K | -544.5% | $-732.9K | $-1.8M | $— | — |
| Q1 null | $0.00 | NaN% | $-606.3K | $-1.5M | $— | — |
| Q4 null | $1.5K | 100.0% | $-445.6K | $-1.2M | $— | — |
| FY null | $404.1K | 100.0% | $-2.8M | $7.1M | $— | — |
| Q3 null | $53.8K | 100.0% | $-622.2K | $-1.5M | $— | — |
| Q2 null | $115.3K | 100.0% | $-899.3K | $12.9M | $— | — |
| Q1 null | $233.5K | 100.0% | $-788.1K | $-3.1M | $— | — |
| Q4 null | $153.5K | 100.0% | $-2.7M | $-2.9M | $— | — |
| FY null | $1.6M | 100.0% | $-2.2M | $-10.6M | $— | — |